Raymond James Starts Aardvark Therapeutics Inc (AARD) at Strong Buy, PT $47, 'we think this name is worth a hard look right here'
Tweet Send to a Friend
(Updated - December 2, 2025 4:06 PM EST)
Raymond James analyst Chris Raymond initiates coverage on Aardvark Therapeutics Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Raymond James analyst Chris Raymond initiates coverage on Aardvark Therapeutics Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
